109 related articles for article (PubMed ID: 2448989)
1. The detection of basal cell determinants in human basal cell carcinomas using two different monoclonal antibodies.
Habets JM; Tank B; Vuzevski VD; van Reede EC; Stolz E; van Joost T
Acta Derm Venereol; 1987; 67(5):391-8. PubMed ID: 2448989
[TBL] [Abstract][Full Text] [Related]
2. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
3. Absence of cytokeratin 8 and inconsistent expression of cytokeratins 7 and 19 in human basal cell carcinoma.
Habets JM; Tank B; Vuzevski VD; Brevé J; Stolz E; van Joost T
Anticancer Res; 1988; 8(4):611-6. PubMed ID: 2460019
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors.
Barbaud A; Simon M; Parache RM; Serre G
Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887
[TBL] [Abstract][Full Text] [Related]
6. [Proliferative activity of basal cell and metatypical cell carcinoma of the skin].
Kazantseva IA; Khlebnikova AN; Babaev VR; Fager G
Arkh Patol; 1994; 56(4):35-8. PubMed ID: 7848103
[TBL] [Abstract][Full Text] [Related]
7. Expression of cytokeratin 8 in basal cell carcinoma: a comparative immunohistochemical and immunoelectron microscopy study.
Kooy AJ; Tank B; de Jong TA; Vuzevski VD; Bosman FT; van Joost T
Anticancer Res; 1996; 16(1):277-82. PubMed ID: 8615621
[TBL] [Abstract][Full Text] [Related]
8. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
9. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
10. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
Mitcov M; Scrivener Y; Cribier B
Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature.
Ali F; Brown A; Gottwald L; Thomas J
J Cutan Pathol; 2005 Jul; 32(6):445-8. PubMed ID: 15953381
[TBL] [Abstract][Full Text] [Related]
12. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas.
Koseoglu RD; Sezer E; Eyibilen A; Aladag I; Etikan I
J Cutan Pathol; 2009 Sep; 36(9):958-65. PubMed ID: 19187116
[TBL] [Abstract][Full Text] [Related]
13. [The localization of structurally specific antigens in squamous cell skin cancer using monoclonal antibodies to epidermal antigens].
Kogan MG; Berenbeĭn BA; Drobyshevskaia EI; Abyzov VN; Spitsin SV
Vopr Onkol; 1989; 35(9):1032-6. PubMed ID: 2479174
[TBL] [Abstract][Full Text] [Related]
14. Detection of malignant melanoma with monoclonal antibodies.
Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ
Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264
[TBL] [Abstract][Full Text] [Related]
15. Loss of bullous pemphigoid antigen in peritumoral lacunas of basal cell carcinomas.
Mérot Y; Faucher F; Didierjean L; Saurat JH
Acta Derm Venereol; 1984; 64(3):209-13. PubMed ID: 6204481
[TBL] [Abstract][Full Text] [Related]
16. Identification of mononuclear cells infiltrating basal cell carcinomas.
Claudy AL; Viac J; Schmitt D; Alario A; Thivolet J
Acta Derm Venereol; 1976; 56(5):361-5. PubMed ID: 78620
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of nerve fibres in basal cell carcinoma.
Panuncio A; Vignale R; Lopez G
Eur J Dermatol; 2003; 13(3):250-3. PubMed ID: 12804983
[TBL] [Abstract][Full Text] [Related]
18. Expression of interferon-gamma receptors and interferon-gamma-induced up-regulation of intercellular adhesion molecule-1 in basal cell carcinoma; decreased expression of IFN-gamma R and shedding of ICAM-1 as a means to escape immune surveillance.
Kooy AJ; Tank B; Vuzevski VD; van Joost T; Prens EP
J Pathol; 1998 Feb; 184(2):169-76. PubMed ID: 9602708
[TBL] [Abstract][Full Text] [Related]
19. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
20. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
Stashower ME; Smith K; Corbett D; Skelton HG
J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
